Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast
Sensei Biotherapeutics, Inc. has suddenly landed back on traders’ radars. After months of drifting as a tiny, cash‑rich micro‑cap biotech, the stock exploded higher at the start of December 2025 – just weeks after the company killed its lead drug program and launched a strategic review.
